Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: a patent review (2014-present) One of the most common and deadliest disease on record is lung cancer. According to estimates with increasing incidence each year, about 85% of lung cancer cases are non-small cell lung cancer type, and about […]
Parsian Pharama Review of CDK4/6 Inhibitors Citing to the Recent Articles
Parsian pharama review of CDK4-6 inhibitors citing to the recent articles One of the most common cancers among women is Breast cancer. Sometimes the average risk of developing breast cancer in a woman in the United States in her lifespan is about 13%. More than 70% of breast cancer cases are Hormone receptor–positive (HR+) types, […]
Aromatase Inhibitors
Parsian pharma review of aromatase inhibitors (AIs) citing to the recent articles regard this subject: Key points that led Parsian pharma to choose Letrozole over other aromatase inhibitors Cell growth in breast cancer is essentially derived by estrogen in both premenopausal and postmenopausal women. Most of the breast cancer cases are among postmenopausal women, […]
Some Tips for Patients who are Taking a CDK4/6 Inhibitor
Some Tips for Patients who are Taking a CDK4/6 Inhibitor CDK4/6 inhibitors are pills taken orally and mostly they are prescribed along with hormonal therapy. If you are taking a CDK4/6 inhibitor, in this article Parsian pharma have some recommendations that can help things go more easily. Create a system for organizing your medications Ask your […]
A Quick Review Over Leukemia
What is leukemia? Leukemia is a cancer of the blood-forming tissues, like the lymphatic system and the bone marrow. There are several broad categories of blood cells, including white blood cells (WBCs), platelets and red blood cells (RBCs). Mostly, leukemia refers to cancers of the WBCs. It is characterized by a large rise in the numbers […]
Tyrosine kinase Inhibitors for Acute lymphocytic leukemia
Tyrosine kinase inhibitors for acute lymphocytic leukemia (ALL) What is acute lymphocytic leukemia (ALL)? Acute lymphocytic leukemia which is called ALL, is an aggressive form of leukemia, in which too many lymphoblasts or lymphocytes are presented in the peripheral blood and bone marrow. In acute lymphocytic leukemia (ALL), cancer can spread to other part of […]
Chronic Myeloid Leukemia (CML)
A quick overview over chronic myeloid leukemia (CML) Chronic myeloid leukemia (CML) is an uncommon form of the bone marrow cancer. In CML we can see an increased number of white blood cells (WBC) in the blood. Too many blood stem cells become a type of WBC which is called granulocytes. They aren’t healthy white blood cells and are […]